
C7  - pp. 1-486
TI  - English to Spanish
SN  - 9781118237977
UR  - https://doi.org/10.1002/9781118797907.ch1
DO  - doi:10.1002/9781118797907.ch1
SP  - 1-486
KW  - Absolute accuracy
KW  - Absorbance
KW  - Absorption paper
KW  - Abundance ratio
KW  - Acclimatisation
KW  - Backdonation
KW  - Backextraction
KW  - Balanced reaction
KW  - Barff process
KW  - Barium acetate
KW  - Carbon
KW  - Cacao butter
KW  - Cacodylic acid
KW  - Cadmium acetate
KW  - Cacodyl chloride
KW  - Dactinomycin
KW  - Dahllite
KW  - Dahmenite
KW  - Dark resistance
KW  - Darmstadtium
KW  - E-book
KW  - E-mail
KW  - Ecgonine
KW  - Eclogite
KW  - Eclampsia
KW  - Fabianol
KW  - Face-centered cubic
KW  - Factor analysis
KW  - Fahrenheit degree
KW  - False positive
KW  - Gabriel reaction
KW  - Gadoleic acid
KW  - Gadolinium bromide
KW  - Galactorrhea
KW  - Galenite
KW  - Haemochrome
KW  - Haemophilia
KW  - Hafnium disulphide
KW  - Halogenating agent
KW  - Hamiltonian mechanics
KW  - Iatrogenic disease
KW  - Iceland moss
KW  - Ichthyocolla
KW  - Icosahedron
KW  - Identity period
KW  - Jacobsen rearrangement
KW  - Janovsky reaction
KW  - Jasmine oil
KW  - Jasmone
KW  - Jeweller's rogue
KW  - Kairomone
KW  - Kappa receptor
KW  - Kava kava
KW  - Keesom relationship
KW  - Kelvin effect
KW  - Lab apparatus
KW  - Lab coat
KW  - Labyrinth
KW  - Labradorite
KW  - Lycopodium
KW  - Macrobiotic diet
KW  - Magnesium bromide
KW  - Maintenance medications
KW  - Magnetisability
KW  - Magnetoencephalograph
KW  - Nalorphine
KW  - Nano-electronics
KW  - Naphthyl alcohol
KW  - Natrolite
KW  - Natural alloy
KW  - Obermayer reagent
KW  - Occlusion
KW  - Ohm's law
KW  - Olfactory cells
KW  - Olfactory stimulation
KW  - Palate
KW  - Palindrome
KW  - Pamoic acid
KW  - Palmitolic acid
KW  - Palmitoyl chloride
KW  - Quadruple resonance
KW  - Qualitative analysis
KW  - Quantitative inheritance
KW  - Quantitative reaction
KW  - Quantum equivalence
KW  - Racemic acid
KW  - Radiation absorber
KW  - Radiation effect
KW  - Radiation hazard
KW  - Radio-carbon
KW  - Radiative capture
KW  - Sabinol
KW  - Saccharase
KW  - Saccharification
KW  - Sacrificial donor
KW  - Safranine
KW  - Tachiol taconite
KW  - Tacrine
KW  - Tactic polymer
KW  - Tactosol
KW  - Ullman reaction
KW  - Ulmin ulcer
KW  - Ultiva
KW  - Ultraviolet radiation
KW  - Vaccination
KW  - Vacuum crystalliser
KW  - Valence transition
KW  - Valeraldehyde
KW  - Valerian oil
KW  - Wacker reaction
KW  - Wagnerite
KW  - Warfarin
KW  - Water sterilisation
KW  - Water still
KW  - X chromosome
KW  - X-ray analysis
KW  - Xenol
KW  - Xenon
KW  - Xenylamine
KW  - Y chromosome yacca gum
KW  - Yttrium nitrate
KW  - Yttrium oxide
KW  - Yttrotantalite
KW  - Zaleplon
KW  - Zaratite
KW  - Zeaxanthin
KW  - Zeeman effect
KW  - Zeise sait
PY  - 2014
AB  - Summary This chapter contains sections titled: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Greek Letters
ER  - 

TY  - JOUR
AU  - KORMAN, M. G.
AU  - BOLIN, T. D.
AU  - SZABO, S.
AU  - HUNT, R. H.
AU  - MARKS, I. N.
AU  - GLISE, H.
TI  - Sucralfate: The Bangkok review
JO  - Journal of Gastroenterology and Hepatology
VL  - 9
IS  - 4
SN  - 9781118237977
UR  - https://doi.org/10.1111/j.1440-1746.1994.tb01264.x
DO  - doi:10.1111/j.1440-1746.1994.tb01264.x
SP  - 412
EP  - 415
KW  - growth factors
KW  - oesophagitis
KW  - peptic ulcer
KW  - sucralfate
PY  - 1994
AB  - Abstract Sucralfate is a site-protective ulcer healing drug with a remarkable range of mechanisms of action. Recent studies highlight the capacity of sucralfate to bind basic fibroblast growth factor (bFGF) and deliver it in high concentration to the ulcer. Basic fibroblast growth factor stimulates the production of granulation tissue, angiogenesis and re-epithelization, thus improving the quality of ulcer healing. The effect of sucralfate in reducing parietal cell sensitivity may be another factor important in the lower relapse rate demonstrated after duodenal ulcer healing. Sucralfate has been demonstrated to be efficacious in healing both duodenal and gastric ulcers together with mild oesophagitis, and it is safe for both short-term use and maintenance. In stress ulcer prophylaxis it is as effective as acid suppression or neutralization and has the advantage of lesser rates of nosocomial pneumonia than are demonstrated with antacids or H2 antagonists. The potential advantages of sucralfate lie in the better quality of ulcer healing associated with longer duration of remission.
ER  - 

TY  - JOUR
TI  - Index
JO  - FEBS Letters
VL  - 178
IS  - S1
SN  - 9781118237977
UR  - https://doi.org/10.1016/0014-5793(84)81314-9
DO  - doi:10.1016/0014-5793(84)81314-9
SP  - 1
EP  - 78
PY  - 1984
ER  - 

TY  - JOUR
TI  - Poster - Gastroenterology
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 30
IS  - S4
SN  - 9781118237977
UR  - https://doi.org/10.1111/jgh.13188
DO  - doi:10.1111/jgh.13188
SP  - 28
EP  - 159
PY  - 2015
ER  - 

TI  - β-N-Acetyl-D-Hexosaminidase to Aspartate Aminotansferase
SN  - 9783527300938
UR  - https://doi.org/10.1002/9783527619764.ch1
DO  - doi:10.1002/9783527619764.ch1
KW  - hydrolase
KW  - physiologically
KW  - isozymes
KW  - polypeptide
KW  - molecular mass
PY  - 2015
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2010
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S2
SN  - 9783527300938
UR  - https://doi.org/10.1002/bjs.7051
DO  - doi:10.1002/bjs.7051
SP  - 76
EP  - 202
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstract withdrawn
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 3
IS  - S1
SN  - 9783527300938
UR  - https://doi.org/10.1002/pds.2630030703
DO  - doi:10.1002/pds.2630030703
SP  - S1
EP  - S121
PY  - 1994
ER  - 

TY  - JOUR
TI  - Infectious cost of leisure (Keynote lecture)
JO  - Clinical Microbiology and Infection
VL  - 7
IS  - s1
SN  - 9783527300938
UR  - https://doi.org/10.1111/j.1469-0691.2001.tb00001.x
DO  - doi:10.1111/j.1469-0691.2001.tb00001.x
SP  - 1
EP  - 357
PY  - 2001
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Journal of Peptide Science
JA  - J. Peptide Sci.
VL  - 14
IS  - S1
SN  - 9783527300938
UR  - https://doi.org/10.1002/psc.1090
DO  - doi:10.1002/psc.1090
SP  - 47
EP  - 194
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
VL  - 2
IS  - s3
SN  - 9783527300938
UR  - https://doi.org/10.1034/j.1600-0854.2004.000000131.x
DO  - doi:10.1034/j.1600-0854.2004.000000131.x
SP  - 137
EP  - 164
PY  - 2002
ER  - 

C7  - pp. 57-553
TI  - Drug monographs
SN  - 9781118819593
UR  - https://doi.org/10.1002/9781118819494.ch15
DO  - doi:10.1002/9781118819494.ch15
SP  - 57-553
PY  - 2002
ER  - 

AU  - Larry, John A.
C7  - pp. 409-421
TI  - Metabolic Syndrome and its Impact on Cardiovascular Disease
SN  - 9781118395271
UR  - https://doi.org/10.1002/9781118395318.ch25
DO  - doi:10.1002/9781118395318.ch25
SP  - 409-421
KW  - atherosclerosis
KW  - cardiovascular disease
KW  - metabolic syndrome
PY  - 2002
AB  - Summary Over the past three decades, metabolic syndrome has been a hot topic of research and debate in the literature, with varying definitions proposed by different societies. Some individuals have even questioned whether metabolic syndrome warrants being labeled a syndrome at all, arguing that having metabolic syndrome results in no increase in atherosclerotic risk over that posed by its individual components. In this chapter, the history of the definition of metabolic syndrome is reviewed. The chapter then presents an overview of the currently understood mechanisms of atherosclerosis. Studies involving the impact of metabolic syndrome on subsequent risk of stroke, myocardial infarction, overall cardiovascular disease and mortality are highlighted. The specific mechanisms of metabolic syndrome that influence the risk of atherosclerotic diseases are also reviewed. The chapter concludes with the arguments, both pro and con, regarding the utility of metabolic syndrome.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Pediatric Diabetes
JA  - Pediatric Diabetes
VL  - 16
IS  - S21
SN  - 9781118395271
UR  - https://doi.org/10.1111/pedi.12309
DO  - doi:10.1111/pedi.12309
SP  - 50
EP  - 150
PY  - 2015
ER  - 

TY  - JOUR
AU  - Vissers, D.
AU  - Neels, H.
AU  - Vermandel, A.
AU  - De Wachter, S.
AU  - Tjalma, W. A. A.
AU  - Wyndaele, J-J.
AU  - Taeymans, J.
TI  - The effect of non-surgical weight loss interventions on urinary incontinence in overweight women: a systematic review and meta-analysis
JO  - Obesity Reviews
JA  - Obes Rev
VL  - 15
IS  - 7
SN  - 9781118395271
UR  - https://doi.org/10.1111/obr.12170
DO  - doi:10.1111/obr.12170
SP  - 610
EP  - 617
KW  - Meta-analysis
KW  - obesity
KW  - urinary incontinence
KW  - weight loss
PY  - 2014
AB  - Summary Although the aetiology of urinary incontinence can be multifactorial, in some cases weight loss could be considered as a part of the therapeutic approach for urinary incontinence in people who are overweight. The objective of this study was to review and meta-analyse the effect of non-surgical weight loss interventions on urinary incontinence in overweight women. Web of Science, PubMed, Pedro, SPORTDiscus and Cochrane were systematically searched for clinical trials that met the a priori set criteria. Data of women who participated in non-surgical weight loss interventions (diet, exercise, medication or a combination) were included in the meta-analysis. After removing duplicates, 62 articles remained for screening on title, abstract and full text. Six articles (totalling 2,352 subjects in the intervention groups) were included for meta-analysis. The mean change in urinary incontinence (reported as frequency or quantity, depending on the study) after a non-surgical weight loss intervention, expressed as standardized effect size and corrected for small sample sizes (Hedges' g), was ?0.30 (95%CI?=??0.47 to ?0.12). This systematic review and meta-analysis shows evidence that a non-surgical weight loss intervention has the potential to improve urinary incontinence and should be considered part of standard practice in the management of urinary incontinence in overweight women.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Fundamental & Clinical Pharmacology
VL  - 25
IS  - s1
SN  - 9781118395271
UR  - https://doi.org/10.1111/j.1472-8206.2011.00930.x
DO  - doi:10.1111/j.1472-8206.2011.00930.x
SP  - 1
EP  - 111
PY  - 2011
ER  - 

TY  - JOUR
AU  - Hanada, Masato
AU  - Kimura, Masaharu
AU  - Kitada, Masayuki
AU  - Nakajima, Toshio
AU  - Yamada, Kentaro
AU  - Yoshii, Machiko
TI  - EPIDERMOID CYST OF ACCESSORY SPLEEN
JO  - Pathology International
VL  - 31
IS  - 5
SN  - 9781118395271
UR  - https://doi.org/10.1111/j.1440-1827.1981.tb02811.x
DO  - doi:10.1111/j.1440-1827.1981.tb02811.x
SP  - 863
EP  - 872
PY  - 1981
AB  - A case of a 51-year-old male with calcified epidermoid cyst arising from an accessory spleen in the tail of the pancreas is reported. This appears, to the best of our knowledge, to be the first report of such a case.
ER  - 

TY  - JOUR
TI  - ABSTRACTS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 20
IS  - s2
SN  - 9781118395271
UR  - https://doi.org/10.1111/j.1530-0277.1996.tb01181.x
DO  - doi:10.1111/j.1530-0277.1996.tb01181.x
SP  - 4A
EP  - 147A
PY  - 1996
ER  - 

TY  - JOUR
AU  - Bassetti, D.
AU  - Bassetti, M.
AU  - Tillotson, G.
AU  - Watson, S.
TI  - Abstracts of the 2nd International Meeting on Antimicrobial Chemotherapy in Clinical Practice, Portofino, Italy, October 21–24, 2001
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 21
IS  - 11P3
SN  - 9781118395271
UR  - https://doi.org/10.1592/phco.21.19.331S.34435
DO  - doi:10.1592/phco.21.19.331S.34435
SP  - 331S
EP  - 388S
PY  - 2001
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 43
IS  - S31
SN  - 9781118395271
UR  - https://doi.org/10.1002/ppul.20939
DO  - doi:10.1002/ppul.20939
SP  - 202
EP  - 462
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
JA  - American Journal of Transplantation
VL  - 14
IS  - S2
SN  - 9781118395271
UR  - https://doi.org/10.1111/ajt.12617
DO  - doi:10.1111/ajt.12617
SP  - 51
EP  - 108
PY  - 2014
AB  - First page of article
ER  - 
